Recombinant HPV vaccine (multitype, E. coli expression)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant HPV vaccine (multitype, E. coli expression), covering 2025-11-21 to 2025-11-21. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) [Phase 3]